Global Endoscopic Submucosal Dissection Market to Reach US$931.6 Million by 2030
The global market for Endoscopic Submucosal Dissection estimated at US$718.7 Million in the year 2024, is expected to reach US$931.6 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Gastroscopes & Colonoscopes, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$260.3 Million by the end of the analysis period. Growth in the Knives segment is estimated at 5.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$195.8 Million While China is Forecast to Grow at 8.0% CAGR
The Endoscopic Submucosal Dissection market in the U.S. is estimated at US$195.8 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$191.5 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.
Global Endoscopic Submucosal Dissection (ESD) Market – Key Trends & Drivers Summarized
How Is Endoscopic Submucosal Dissection Transforming Gastrointestinal Oncology?
Endoscopic Submucosal Dissection (ESD) is an advanced endoscopic technique used for en bloc resection of early-stage gastrointestinal cancers and precancerous lesions. ESD allows complete removal of tumors in the esophagus, stomach, and colon without requiring open surgery, making it a highly effective alternative to traditional surgical excision. This procedure has gained significant traction in the treatment of early gastric cancer, esophageal squamous cell carcinoma, and colorectal neoplasms, particularly in regions such as Japan, South Korea, and Europe, where screening programs have improved early cancer detection.
The advantages of organ preservation, reduced recurrence rates, and minimal post-procedural complications have led to growing adoption of ESD in gastroenterology. Additionally, the expansion of endoscopic training programs and AI-assisted tumor identification tools has improved the availability and success rates of ESD procedures worldwide. As oncologists and gastroenterologists seek more effective, minimally invasive cancer treatment options, demand for specialized ESD instruments and techniques is rising.
What Are the Key Innovations in Endoscopic Submucosal Dissection?
The development of high-precision ESD knives, real-time endoscopic imaging, and AI-powered lesion detection algorithms has significantly improved the accuracy and safety of tumor resections. Electrosurgical ESD knives with water-jet-assisted dissection have enhanced submucosal tissue separation, reducing bleeding risks and improving en bloc resection rates.
Additionally, robot-assisted endoscopic systems are being developed to improve precision and operator control during complex ESD procedures. AI-driven deep-learning algorithms integrated into endoscopic imaging platforms are enhancing early cancer detection and classification, ensuring better patient outcomes. The integration of virtual reality (VR)-based ESD training modules has also accelerated the skill development of gastroenterologists, expanding access to highly specialized ESD techniques globally.
What Is Driving the Growth of the Endoscopic Submucosal Dissection Market?
The growth in the ESD market is driven by rising gastrointestinal cancer incidence, increased adoption of minimally invasive tumor resection techniques, and advancements in AI-assisted endoscopic imaging. The expansion of cancer screening programs, particularly in high-risk regions, has improved early detection rates, increasing demand for ESD as a primary treatment option.
Additionally, increasing investments in endoscopy training, AI-powered diagnostics, and robotic-assisted ESD systems have contributed to higher procedural success rates and improved patient recovery times. As healthcare providers continue to prioritize non-invasive, organ-sparing treatment modalities, the global adoption of ESD is expected to grow, reshaping early gastrointestinal cancer management and treatment paradigms.
SCOPE OF STUDY:Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook